Study shows new drugs may not be enough to reduce heart attacks

March 19, 2014

(Medical Xpress)—Researchers have found a new class of drugs can improve the ability of particles in the blood which can increase so-called 'good' cholesterol's ability to clear away fat from blood vessel walls.

The reduction of furring up of blood vessels – called atherosclerosis by - relies on reducing the amount of fat laid down in the vessel wall for example by taking statins or by improving the efficacy of good cholesterol which carries fat deposits away from the blood vessel lining.

Patients with higher levels of good cholesterol have a lower risk of heart attacks.

In this new study, published in the European Heart Journal and the largest one carried out so far to look at function, experts examined the effects of these drugs - called CETP inhibitors - on the special particles and the overall good cholesterol levels.

Professor Kausik Ray, of St George's, University of London, said: "Generally, medical experts have attempted to develop drugs that raise good cholesterol levels believing that raising good cholesterol would prevent heart attacks. Some of these drugs turned out to be harmful whereas others showed no benefit but also no harm despite raising good cholesterol by 30%.

The question remains therefore is this viable method for reducing heart attacks and strokes.

Our study looked at what the so called good cholesterol particles did and whether the drug improved the function or efficiency of these particles.

"We found that the good cholesterol particles did increase in number and function but by a modest 10% despite raising good cholesterol overall by 30%.

"So there is a discrepancy between cholesterol levels in good particles and how they are working and simply raising with having significant effect on function may not be enough.

"It is possible that the way that these particles work is more important than the overall levels of cholesterols they carry and only by increasing function much more are these types of drugs likely to be effective.

"Importantly this also suggests that more work needs to be done to see how function is related to heart attacks."

Explore further: Early atherosclerotic plaques regress when cholesterol levels are lowered

Related Stories

Early atherosclerotic plaques regress when cholesterol levels are lowered

February 27, 2014
Early but not advanced forms of atherosclerotic plaques in the vessel wall disappear when the levels of 'bad' cholesterol are lowered, according to a study in mice from Karolinska Institutet, Sweden. The findings, published ...

Low HDL-cholesterol—Not quantity, but quality

April 30, 2013
Many of the genes regulating the inflammation and immune response of the body are also associated with low HDL-cholesterol levels in the circulation, tells the recent study conducted at the University of Helsinki, Finland. ...

Calcium and vitamin D improve cholesterol in postmenopausal women

March 5, 2014
Calcium and vitamin D supplements after menopause can improve women's cholesterol profiles. And much of that effect is tied to raising vitamin D levels, finds a new study from the Women's Health Initiative (WHI) just published ...

Increased intake of fish can boost good cholesterol levels

March 3, 2014
(Medical Xpress)—Increasing the intake of fatty fish increases the number of large HDL particles, according to a recent study completed at the University of Eastern Finland. People who increased their intake of fish to ...

Advances in cholesterol-lowering drugs within five years

February 3, 2014
(Medical Xpress)—A leading cardiology expert at the University of Adelaide predicts that a new class of advanced cholesterol-reducing drugs could be ready for patient use within the next five years, helping to prevent heart ...

Low-dose statins good option for some heart patients, study finds

February 10, 2014
(HealthDay)—A new analysis suggests that people at high risk for heart disease who can't take high-dose statin drugs to lower their cholesterol might benefit from a treatment combination that includes taking a low-dose ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.